• Home

Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review

Pituitary, 07/09/2013

Chiloiro S et al. – Ki–67 Labeling Index is an immunocytochemical marker of cell proliferation. The correlation of Ki–67 expression with pituitary adenomas recurrence has been investigated and is highly debated. Aim of this study was to evaluate whether Ki–67 correlates with recurrence even in patients with an apparently completely removed pituitary adenoma. This was associated with worse disease–free survival time, even after correction for age at treatment, gender, positivity to p53, functional classification and Knosp grading. Ki–67 labeling index may be useful in postoperative management, even in patients who underwent radical PA removal. The authors suggest a Ki–67 cut–off value of 1.5 % to plan an adequate clinical follow–up.


Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now

  • CalendarPNAJune


Continuing Education Program

Knowledge Icon 500

If you are a nurse or medical professional, register for PNA CEU Membership and  earn CEU credits to learn about the symptoms, diagnosis and treatment options for patients with pituitary disorders. Help PNA reduce the time it takes for patients to get an accurate diagnosis.

button registerNow

For more information click here!